About isatuximab
Anti-CD38 monoclonal antibody
Used for
- Multiple myeloma, with other cancer medicines, in adults who have received previous treatment.
Usual adult dose
10 mg/kg by intravenous infusion, usually weekly for four weeks, then every two weeks; regimen depends on accompanying medicines.
Common side effects
- Infusion reactions
- Pneumonia or other infections
- Diarrhea, nausea, or vomiting
- Low blood-cell counts
Important warnings
- Infusion reactions can be severe; monitoring and premedication are required.
- Can cause serious infections and low blood-cell counts.
- May interfere with blood compatibility testing; notify the blood bank before transfusion.
- May harm an unborn baby; effective contraception is required during treatment and for five months afterward.
Pregnancy
May cause fetal harm. Avoid during pregnancy; effective contraception is required during treatment and for five months after the last dose.
Breastfeeding
Breastfeeding is not recommended during treatment and for five months after the last dose.
Interactions
- No major drug interactions are established; check all medicines with the oncology team.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.